Christophe Ancel

Christophe Ancel has extensive experience in quality assurance and operations within the pharmaceuticals and biotech sectors. Currently serving as Vice President of Pharmaceutical Operations and Quality at Transgene since February 2008, Christophe Ancel manages quality systems including documentation, change control, audits, and training, while overseeing a team of nine. Prior to this role, independent consulting activities encompassed quality training, audits, and regulatory consulting for major clients such as Novartis and Pierre Fabre. Previous experience includes positions at Eli Lilly and Company, where Christophe Ancel was Quality Assurance Manager, and at Catalent Pharma Solutions as Site Quality Leader. Additionally, an extensive tenure at Alcon focused on aligning quality systems with ISO and FDA standards.